CWM
ADMA icon

CIBC World Markets’s ADMA Biologics ADMA Stock Holding History

CIBC World Markets’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$280K Buy
+15,338
New +$259K ﹤0.01% 985
2025
Q2 		$520K Sell
28,567
-22,401
-44% -$457K ﹤0.01% 852
2025
Q1 		$1.01M Buy
50,968
+29,892
+142% +$517K 0.01% 688
2024
Q4 		$361K Buy
+21,076
New +$397K ﹤0.01% 857

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

CIBC World Markets's ADMA Position: Q4 2025 in Review

CIBC World Markets opened a new position in ADMA Biologics (ADMA) in Q4 2025: 15,338 shares worth $280K. The stake represents ﹤0.01% of the portfolio and ranks #985 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in ADMA as recently as Q2 2025.

CIBC World Markets first reported a position in ADMA in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.01M in Q1 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q4 2025.

  • CIBC World Markets held 15,338 shares of ADMA Biologics worth $280K as of Q4 2025.
  • ADMA Biologics was a new CIBC World Markets position in Q4 2025.
  • ADMA Biologics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #985 holding.
  • CIBC World Markets first reported a position in ADMA Biologics in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's ADMA Biologics position peaked at $1.01M in Q1 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.